Kim, R. D., Fan, X., Sabater, J., Su, W., Hurwitz, K., Hendrickson, K., Bennett, K., Wiener, C., Garfin, P. M., Zape, J., Ozog, M., Bridgewater, J., Valle, J. W., Dayyani, F. (2025). Survival outcomes for zanidatamab-hrii compared to chemotherapy in previously treated HER2-positive (IHC3+) biliary tract cancer (BTC): HERIZON-BTC-01 vs a real-world (RW) external control arm (ECA).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4101